Showing results (481-490 of 494) with videos related to
Sort By:
Pageof 50
Cancers|March 10, 2022
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast CancerNour Abuhadra, Ryan Sun, Jennifer K Litton, et al.Nature Communications|August 31, 2016
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityChia-Wei Li, Seung-Oe Lim, Weiya Xia, et al.Cell Metabolism|June 17, 2023
Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenationYaohua Zhang, Zilong Zhao, Lisa A Huang, et al.Human Pathology|January 22, 2022
Expression of TRPS1 in phyllodes tumor and sarcoma of the breastJing Wang, Wei-Lien Wang, Hongxia Sun, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†A M Gonzalez-Angulo, A Akcakanat, S Liu, et al.British Journal of Cancer|April 2, 2021
CD8+ T cells inhibit metastasis and CXCL4 regulates its functionRobiya Joseph, Rama Soundararajan, Suhas Vasaikar, et al.Nature Cell Biology|January 22, 2008
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradationJer-Yen Yang, Cong S Zong, Weiya Xia, et al.Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.Cancer Cell|February 14, 2018
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1Chia-Wei Li, Seung-Oe Lim, Ezra M Chung, et al.Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.Pageof 50